| 1 |
33200293 | Synthesis and evaluation of ursolic acid-based 1,2,4-triazolo[1,5-a]pyrimidines derivatives as anti-inflammatory agents. | 2022 Feb |
2 |
| 2 |
34515014 | Molecular and Metabolomic Investigation of Celecoxib Antiproliferative Activity in Mono-and Combination Therapy against Breast Cancer Cell Models. | 2022 |
2 |
| 3 |
35176901 | Celecoxib Synergistically Enhances MLN4924-Induced Cytotoxicity and EMT Inhibition Via AKT and ERK Pathways in Human Urothelial Carcinoma. | 2022 Jan-Dec |
2 |
| 4 |
35361388 | The effect of celecoxib for treatment of preterm labor on fetuses during the second trimester of pregnancy: A pilot case series. | 2022 Mar |
1 |
| 5 |
35590388 | Randomized double-blind, placebo-controlled study of topical diclofenac in the prevention of hand-foot syndrome in patients receiving capecitabine (the D-TORCH study). | 2022 May 19 |
2 |
| 6 |
35603760 | Quadruple Functionalized Pyrazole Pharmacophores by One-pot Regioselective [3+2] Cycloaddition of Fluorinated Nitrile Imines and Dicyanoalkenes. | 2022 May 23 |
1 |
| 7 |
32887541 | Tablet Formulation of a Synthesized Celecoxib Potassium Salt and Development of a Validated Method for Its Analysis. | 2021 |
2 |
| 8 |
33152664 | Silencing COX-2 blocks PDK1/TRAF4-induced AKT activation to inhibit fibrogenesis during skeletal muscle atrophy. | 2021 Jan |
2 |
| 9 |
33160981 | Celecoxib promotes survival and upregulates the expression of neuroprotective marker genes in two different in vitro models of Parkinson's disease. | 2021 Aug 15 |
2 |
| 10 |
33164600 | Celecoxib and Afatinib synergistic enhance radiotherapy sensitivity on human non-small cell lung cancer A549 cells. | 2021 |
3 |
| 11 |
33427075 | Identification of novel potential cyclooxygenase-2 inhibitors using ligand- and structure-based virtual screening approaches. | 2021 Jan 10 |
1 |
| 12 |
33511940 | Dual Human Carbonic Anhydrase/Cyclooxygenase-2 Inhibitors: A Promising Approach for Cancer Treatment. | 2021 Oct 28 |
1 |
| 13 |
33658842 | Acute Treatment of Migraine with Celecoxib Oral Solution: Results of a Randomized, Placebo-Controlled Clinical Trial. | 2021 |
2 |
| 14 |
33689795 | Adding high-dose celecoxib to increase effectiveness of standard glioblastoma chemoirradiation. | 2021 Sep |
1 |
| 15 |
33724256 | Effects of celecoxib augmentation of antidepressant or anxiolytic treatment on affective symptoms and inflammatory markers in patients with anxiety disorders: exploratory study. | 2021 May 1 |
1 |
| 16 |
33821899 | Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer: The CALGB/SWOG 80702 (Alliance) Randomized Clinical Trial. | 2021 Apr 6 |
1 |
| 17 |
33873113 | Cyclic mechanical stimulation inhibits rheumatoid arthritis fibroblast-like synoviocytes proliferation via cell cycle arrest. | 2021 May 24 |
1 |
| 18 |
33927776 | Study on the Bioassay of Anti-Inflammatory Effects of Fuke Qianjin Capsule Based on COX-2 Inhibiting Activity. | 2021 |
1 |
| 19 |
34084214 | Cyclooxygenase-2 expression is associated with chemoresistance through cancer stemness property in hypopharyngeal carcinoma. | 2021 Jul |
2 |
| 20 |
34124047 | Identification of Precise Therapeutic Targets and Characteristic Prognostic Genes Based on Immune Gene Characteristics in Uveal Melanoma. | 2021 |
1 |
| 21 |
34141803 | Pelvic lipomatosis with cystitis glandularis managed with cyclooxygenase-2 inhibitor: A case report. | 2021 Jun 16 |
2 |
| 22 |
34356673 | Celecoxib Analogues for Cancer Treatment: An Update on OSU-03012 and 2,5-Dimethyl-Celecoxib. | 2021 Jul 16 |
1 |
| 23 |
34577574 | PRODH/POX-Dependent Celecoxib-Induced Apoptosis in MCF-7 Breast Cancer. | 2021 Aug 29 |
2 |
| 24 |
34592918 | New horizons in the roles and associations of COX-2 and novel natural inhibitors in cardiovascular diseases. | 2021 Sep 30 |
2 |
| 25 |
34609050 | Celecoxib reduces hepatic vascular resistance in portal hypertension by amelioration of endothelial oxidative stress. | 2021 Nov |
2 |
| 26 |
34795522 | Erratum: Suppressing Growth and Invasion of Human Hepatocellular Carcinoma Cells by Celecoxib Through Inhibition of Cyclooxygenase-2 [Corrigendum]. | 2021 |
1 |
| 27 |
31466474 | Risks of Cardiovascular Disease and Beyond in Prescription of Nonsteroidal Anti-Inflammatory Drugs. | 2020 Jan |
1 |
| 28 |
31982687 | Induction of aortic valve calcification by celecoxib and its COX-2 independent derivatives is glucocorticoid-dependent. | 2020 May - Jun |
2 |
| 29 |
32227417 | Epidermal growth factor-induced COX-2 regulates metastasis of head and neck squamous cell carcinoma through upregulation of angiopoietin-like 4. | 2020 Jun |
1 |
| 30 |
32257976 | Cyclooxygenase-2 inhibitors delay relapse and reduce Prostate Specific Antigen (PSA) velocity in patients treated with radiotherapy for nonmetastatic prostate cancer: a pilot study. | 2020 Mar |
1 |
| 31 |
32269737 | Selective EP2 and Cox-2 inhibition suppresses cell migration by reversing epithelial-to-mesenchymal transition and Cox-2 overexpression and E-cadherin downregulation are implicated in neck metastasis of hypopharyngeal cancer. | 2020 |
1 |
| 32 |
32296574 | COX-2 as a potential biomarker and therapeutic target in melanoma. | 2020 Feb 15 |
1 |
| 33 |
32359360 | PET measurement of cyclooxygenase-2 using a novel radioligand: upregulation in primate neuroinflammation and first-in-human study. | 2020 May 2 |
1 |
| 34 |
32595209 | Syntenin-1 promotes colorectal cancer stem cell expansion and chemoresistance by regulating prostaglandin E2 receptor. | 2020 Sep |
1 |
| 35 |
32615181 | MicroRNAs in the anticancer effects of celecoxib: A systematic review. | 2020 Sep 5 |
3 |
| 36 |
32615261 | Celecoxib substituted biotinylated poly(amidoamine) G3 dendrimer as potential treatment for temozolomide resistant glioma therapy and anti-nematode agent. | 2020 Sep 1 |
1 |
| 37 |
32669521 | Comparative efficacy and safety of Verbascox® - a proprietary herbal extract capable of inhibiting human cyclooxygenase-2 - and celecoxib for knee osteoarthritis. | 2020 |
1 |
| 38 |
32762277 | Targeted cyclooxygenase-2 inhibiting nanomedicine results in pain-relief and differential expression of the RNA transcriptome in the dorsal root ganglia of injured male rats. | 2020 Jan-Dec |
1 |
| 39 |
32763585 | Plasma MCP-1 levels in bipolar depression during cyclooxygenase-2 inhibitor combination treatment. | 2020 Oct |
1 |
| 40 |
32806257 | Lipid-based nanocarrier-mediated targeted delivery of celecoxib attenuate severity of ulcerative colitis. | 2020 Nov |
3 |
| 41 |
32899627 | Design and Synthesis of a Novel NIR Celecoxib-Based Fluorescent Probe for Cyclooxygenase-2 Targeted Bioimaging in Tumor Cells. | 2020 Sep 4 |
3 |
| 42 |
32906766 | Anti-Inflammatory Activity and ROS Regulation Effect of Sinapaldehyde in LPS-Stimulated RAW 264.7 Macrophages. | 2020 Sep 7 |
1 |
| 43 |
33014157 | Celecoxib upregulates ULBP-1 expression in lung cancer cells via the JNK/PI3K signaling pathway and increases susceptibility to natural killer cell cytotoxicity. | 2020 Dec |
4 |
| 44 |
33057440 | KSHV G-protein coupled receptor vGPCR oncogenic signaling upregulation of Cyclooxygenase-2 expression mediates angiogenesis and tumorigenesis in Kaposi's sarcoma. | 2020 Oct |
3 |
| 45 |
33116404 | Novel Molecular Mechanism of Aspirin and Celecoxib Targeting Mammalian Neuraminidase-1 Impedes Epidermal Growth Factor Receptor Signaling Axis and Induces Apoptosis in Pancreatic Cancer Cells. | 2020 |
2 |
| 46 |
33172102 | Synthesis, 3D-QSAR, and Molecular Modeling Studies of Triazole Bearing Compounds as a Promising Scaffold for Cyclooxygenase-2 Inhibition. | 2020 Nov 6 |
1 |
| 47 |
33194674 | Metronomic Celecoxib Therapy in Clinically Available Dosage Ablates Hepatocellular Carcinoma via Suppressing Cell Invasion, Growth, and Stemness in Pre-Clinical Models. | 2020 |
2 |
| 48 |
33209192 | Granulosa cell proliferation is inhibited by PGE2 in the primate ovulatory follicle. | 2020 May 21 |
1 |
| 49 |
33255450 | COX-2 Is Downregulated in Human Stenotic Aortic Valves and Its Inhibition Promotes Dystrophic Calcification. | 2020 Nov 24 |
2 |
| 50 |
33260755 | Celecoxib Loaded In-Situ Provesicular Powder and Its In-Vitro Cytotoxic Effect for Cancer Therapy: Fabrication, Characterization, Optimization and Pharmacokinetic Evaluation. | 2020 Nov 28 |
2 |